How many clinical trials are studying Stereotactic Radiotherapy?

5 recruiting trials in our tracked data involve Stereotactic Radiotherapy.

What conditions is Stereotactic Radiotherapy being studied for?

In our tracked recruiting trials, Stereotactic Radiotherapy is being studied in trials for Lung cancer, Prostate Cancer, Lung Neoplasm.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase 2 3 Not applicable 2

Condition	Trials
Lung cancer	2
Prostate Cancer	2
Lung Neoplasm	1
Melanoma	1
Melanoma Stage Iv	1
Non Small Cell Lung Cancer	1
Prostate Cancer (Adenocarcinoma)	1

Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)
NCT03340129 · Phase: Phase 2 · Ages: 18 Years to 120 Years · Sex: All (male and female) · 9 locations
Furmonertinib Combined With Intrathecal Chemotherapy and Stereotactic Radiotherapy (SRT) for EGFR-Mutated NSCLC Patients With Brain Parenchymal and Leptomeningeal Metastases
NCT07304739 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 3 locations
Lu-PSMA and Stereotactic Radiotherapy Versus Radiotherapy Alone for Prostate Cancer (LUST)
NCT05893381 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 2 locations
Stereotactic Radiotherapy of Prostate Cancer With Reduction of Safety Margins
NCT06665932 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
NCT02984761 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 17 locations